Senior insider sale
Interim CFO at AVALO THERAPEUTICS, INC. — senior position signals high conviction
$1.39M
70.71K shares
What this filing means
SULLIVAN CHRISTOPHER RYAN plans to sell 70.71K shares of AVALO THERAPEUTICS, INC. valued at approximately $1.39M. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 8/17/2026ACC: 0001950047-26-008273
Officer· Interim CFO
Since Apr 2020
70.71K
Shares to sell
$1.39M
Approx. market value
70.71K
Acquired (3 months)
1
Planned
Securities Acquired — Last 3 Months1
Exercise of Stock Options
Cash
8/17/2026
70.71KTotal acquired70.71K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
8/17/2026 | Exercise of Stock Options Cash | 70.71K | — |
| Total | 70.71K | ||
Planned & Completed Dispositions1
NASDAQPlanned
Units to sell
70.71K
Market value
$1.39M
8/17/2026
Total
Units
70.71K
Value
$1.39M
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
8/17/2026 | 70.71K | $1.39M | NASDAQ | Planned |
| Total | 70.71K | $1.39M | ||